Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Botulism toxin, bioterrorist weapon].

Philippe Bossi1, François Bricaire

  • 1Service de maladies infectieuses et tropicales Hôpital Pitié-Salpêtrière 47-83 Boulevard de l'Hôpital, 75013 Paris. philippe.bossi@psl.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|May 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Features of Mpox infection: The analysis of the data submitted to the ID-IRI network.

New microbes and new infections·2023
Same author

Bulletin de l'Academie nationale de medecine·2020
Same author

[Emerging viral outbreaks].

Presse medicale (Paris, France : 1983)·2019
Same author

[Emergent and reemergent infectious diseases].

La Revue du praticien·2019
Same author

Emerging risks, bioterrorism, highly transmissible diseases

La Revue du praticien·2018
Same author

Bioterrorism

La Revue du praticien·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Botulism, a severe neuro-paralysing infection, can be a biowarfare agent. Prompt vaccination with a trivalent antitoxin is crucial for exposed individuals following a botulinum toxin aerosol attack.

Area of Science:

  • Microbiology
  • Toxicology
  • Public Health

Context:

  • Botulism is a severe neuro-paralysing infection caused by Clostridium botulinum toxin.
  • The deliberate release of botulinum toxin as an aerosol represents a credible biowarfare threat.
  • Inhalation botulism results from deliberate aerosolized toxin release and presents identical clinical symptoms to other forms.

Purpose:

  • To highlight the potential of botulinum toxin as a biowarfare agent.
  • To emphasize the clinical presentation of inhalation botulism.
  • To outline immediate prophylactic and therapeutic measures in response to a botulinum toxin aerosol attack.

Summary:

  • Botulinum toxin is the most potent known toxin, easily produced and capable of causing mass destruction.

Related Experiment Videos

  • Inhalation botulism, a consequence of deliberate aerosolization, requires rapid intervention.
  • Prophylactic vaccination with a trivalent antitoxin (types A, B, and E) is recommended for exposed individuals, especially those showing symptoms.

    • Impact:

    • A single case of inhalation botulism should be considered an act of terrorism.
    • This underscores the importance of preparedness and rapid response protocols for bioterrorism events involving potent neurotoxins.
    • Highlights the critical role of timely vaccination in mitigating the effects of botulinum toxin exposure.